Accesswire
19 Dec 2025, 14:00 UTC · 43w ago
IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum
Verdict
Headline leans bullish. We score IGC +1.00.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · IGC
+1.00strongly bullish





